MedTrace Logo

Dexamethasone for Post-cesarean Delivery Pain

NCT01812057 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2017-07-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare post-cesarean section consumption of pain medication between two groups of patients undergoing scheduled cesarean section at term gestation who receive a single-dose of intraoperative steroid (dexamethasone 8 milligrams) versus placebo at 24 hours after surgery. The hypothesis is that a single perioperative dose of dexamethasone 8 mg will significantly reduce postoperative opioid consumption at 24 h in women having cesarean delivery under spinal anesthesia.

Conditions

  • Pain, Postoperative
  • Postoperative Nausea and Vomiting

Interventions

DRUG

Dexamethasone

Dexamethasone 8 mg IV (as a one time dose)

DRUG

Placebo

Sodium Chloride 0.9% -5 ml

Sponsors & Collaborators

Principal Investigators

  • Terrence Allen, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2016-05-27
Completion
2016-09-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01812057 on ClinicalTrials.gov